Shanghai Fosun Pharmaceutical (HKG:2196, SHA:600196) plans to repurchase shares in Shanghai and Hong Kong, according to a Wednesday filing with the Hong Kong Exchange.
The drug company aims to buy back up to 27,597,025 shares in Hong Kong, the filing said.
Fosun Pharma plans to buy between 300 million yuan and 600 million yuan of shares in Shanghai. Proceeds from the Shanghai share buybacks will be used to issue shares for convertible bond conversion, and for employee incentive plans, the filing said.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.